ISPOR Poland Chapter Annual Report 2010

Size: px

Start display at page:

Download "ISPOR Poland Chapter Annual Report 2010"

Lewis Lang
6 years ago
Views:

ISPOR Poland Chapter Annual Report 2010 TO: Board of Directors International Society for Pharmacoeconomics and Outcomes Research 3100 Princeton Pike, Suite 3E Lawrenceville, NJ 08648 USA Background:

1 ISPOR Poland Chapter Annual Report 2010 TO: Board of Directors International Society for Pharmacoeconomics and Outcomes Research 3100 Princeton Pike, Suite 3E Lawrenceville, NJ USA Background: PREPARED BY: Prof. Karina Jahnz-Rozyk, PhD Head of Department of Immunology & Allergology Military Institute of Health Service poczta.onet.pl The Poland Chapter was established in January The Chapter consists has 140 members. The current Board of Directors of Poland Chapter is comprised of the following: President Prof. Karina Jahnz-Rozyk, MD, PhD Head of Department of Immunology & Allergology Military Institute of Medicine President-Elect Joanna Lis, PhD Manager, Health Economics Department Sanofi-Aventis Past President Prof. Tomasz Hermanowski, PhD Head of Department of Pharmacoeconomics Medical University of Warsaw Secretary Slawomir From, MD, PhD Department of Internal Medicine, Pneumonology& Allergology Military Institute of Medicine Treasurer Prof. Tomasz Targowski, PhD

2 Department of Internal Medicine, Pneumonology& Allergology, Military Institute of Medicine Member Prof. Marcin Czech, PhD, MD, MBA Department of Pharmacoeconomics Medical University of Warsaw For more information on the Poland Chapter, please visit the ISPOR Regional Chapter website at or ISPOR Poland Chapter Annual Report 2010 Activities/ Accomplishments Summary 1. Organisation of The 8 th Scientific Conference of the Polish Society of Pharmacoeconomics (December 2010): Health Capital, 2. Scientific and educational activities: 9 published papers, 11 lectures, 2 ISPOR Forums, 1 workshop, 2 podium presentations, 17 poster presentations,

3 3. Five scientific sections was formed by PTFe Scientific / Educational Activities Papers: 1. J. Lis: The costs of illnesses and their public funding in Europe in Health Care and Economy with scientific edition of K. Rycia and Z. Skrzypczak, K.Jahnz-Różyk: Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland. Pol.Merk.Lek., 2010, 29, 169, K.Jahnz-Różyk: Pharmacoeconomics aspects of longacting beta-2 agonists in COPD patients. Pol.Merk.Lek., 2010, 28, 166, Golicki D., Jakubczyk M., Niewada M., Wrona W., Busschbach J.: Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value in Health, 2010, 13, 2, Jakubczyk M., Wrona W., Macioch T., Golicki D., Niewada M., Hermanowski T:.: Indirect costs in Health Technology Assesments. Pol.Merk.Lek., Vol. 28, No 163, January 2010, p Robert Kranc, Marcin Czech.: Educational needs in pharmacoeconomics of medical students in Poland Farm Pol 2010, 66(7): Marcin Czech Drugs management based on pharmacoeconomic criteria- comparative analysis of Central European countries Haelthcare and Economy with scientific edition with Kazimierz Ryc and Zofia Skrzypczak, Warsaw 2010: Marcin Czech - Pharmacoeconomics and health technology assessment in drug management in Poland. Diagnosis and future perspectives. A book by Wolters 9. TomaszHermanowskiAnna Zawada,Dominika Radzymińska, Anna Staszewska-Bystrova, Victor Bystrov Metodological Aspects of analysis of financing models impact on Healthcare quality, Haelthcare and Economy with scientific edition by Kazimierz Ryc and Zofia Skrzypczak Warsaw 2010 Lectures: I. K. Jahnz-Różyk: Exacerbations of COPD in Polandeconomical impact. COPD Forum, Warsaw 8 th - 9 th January, 2010,

4 II. K.Jahnz-Różyk: Pharmacoeconomics of Specific Immunotherapy in Poland. Lectures given at Polish Society of Allergology Meetings, Warsaw, 9 th Jan 2010, Wisła, 27 th March, III. K.Jahnz-Różyk: Pharmacoeconomics of COPD. Lecture given during conference Integrated care for patients with advanced chronic obstructive pulmonary disease- a new approach to organization, sponsored by chancellor of Medical University in Gdansk, Gdańsk, 28,th May, IV. K.Jahnz-Różyk: Costs of COPD Therapy. Lecture given during XXXI th Conference of Polish Thoracic Society, Mikołajki, 1 th 4 th September, V. K.Jahnz-Różyk: Costs of COPD. Lecture given at Conference Reducing the Burden of COPD, Warsaw, 24 th Sep 2010, VI. J.Lis: Regional approach to health care problems - the cost of treating rheumatoid arthritis in Poland and the world. Speech at the conference of Warsaw University, Faculty of Management, 15 th April, 2010, with the presentation on, VII. J.Lis: Fundamentals of pharmacoeconomics. Presentation on during the XIII SCIENCE and EDUCATION CONGRESS of Polish Society of Clinical Oncology in Sopot, 3 September, 2010 VIII. M.Czech.: "Health Technology Assessment- is it really unavoidable in Central and Eastern Europe?" during the Next Level Pharma conference Pharmaceutical Pricing & Reimbursement in Central & Eastern Europe 7th-8th June, 2010, Budapest, IX. M.Czech:"Pharmacoeconomics- the Polish perspective" during a conference Changing EU Requirements and their National Impact, Warsaw, 28 May 2010, X. M.Czech: Pharmaceutical market potential in the countries of Central and Eastern Europe based on demographic, economic and social indicators" during a conference Healthcare and economy, Warsaw University, April 2010 Faculty of Management, XI. M.Czech: "Pharmacoeconomics- the Polish perspective" during a conference Changing EU Requirements and their National Impact, Warsaw 28 May 2010

5 Policy-Related Activities 1. Work on the PTFE position of for a new Act of reimbursement under the public consultation (J.Lis, T.Hermanowski, M.Czech) 2. Participation in public debates: K.Jahnz-Rozyk, K. Jahnz-Różyk: Costs of influenza and reimbursement of flu vaxines in Poland, endorsement by Ministry of Health in Poland, 11 th October, 2010, Warsaw K. Jahnz-Różyk.: Biosimilar medicineseffectiveness, safety and regulatory aspects. Debate on Medicines in Poland, 28 th October 2010, Warsaw Conferences 1. The 8 th Scientific Conference of the Polish Society of Pharmacoeconomics (December 2010): Health Capital Keynote speakers - Imre Bonch (Hungary), Oleg Borisenko (Russia), Marcin Czech (Poland), Dan Greenberg (Israel), Tomasz Hermanowski (Poland), Shanlian Hu (China), Karina Jahnz-Rozyk (Poland), Bengt Joensson(Sweden), Joanna Lis (Poland), Wojciech Matusewicz (Poland), Jacek Spławiński (Poland), Thomas Szucs (Switzerland), Pawel Vorobyew (Russia), Vladimir Zah (Serbia), The Conference Programme included: 3 scientific workshops, Polish-Russian Session, Plenary Sessions with invited guests, International ISPOR Session, Polish Pharmacoeconomic Society,s session, poster discussion, 5 th edition of the Best Pharmacoeconomic Researchers ( bachelor s degree essay, master s thesis, doctoral thesis) th Annual International Meeting, May,2010, Atlanta,: GA, USA: Forum ISPOR: Poland-Russia; K.Jahnz-Rozyk, J. Lis: Access to the biological treatment in Poland, Cost-effectiveness and direct costs of specific immunotherapy in Poland 3 years retrospective study, Poster Presentation, K.Jahnz-Różyk, T.Targowski, P.Przekora, ISPOR, 15 th Annual

6 International Meeting, May,2010, Atlanta,: GA, USA th European ISPOR Congress, Prague, Czech Republic : J. Lis: Co-Chair of Issue Panel Review Committee. M. Czech: Member of Advisory Board Forum ISPOR: Serbia, Greece, Poland; K.Jahnz-Różyk, J. Lis: Linking today,s decisions with tomorrow possibilities perspective from Poland, Workshop: Hermanowski T., Financing Coordinated Care in the European Union, Maedical University of Warsaw, International Research Project on Financing Quality in Healthcare InterQuality Podium Presentations: 1. Psychometric Comparison of EQ-5D in Student Population, Golicki D., Zawodnik Sz., Janssen MF., Kiljan A., Hermanowski T.; abstrakt w Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 240; 2. Cost of Absenteeism Due to Cancer in Poland, Macioch T., Hermanowski T., Adamowicz O., abstrakt w Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 239; Poster Presentations: 1. Direct costs of chronic obstructive pulmonary disease in Poland, Poster Presentation, K. Jahnz-Różyk, T.Targowski, S.From, T.Faluta, Ł. Borowiec, abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November Assessing Productivity and Activity Impairment Due to Illness in Poland, Poster Presentation, Wrona W., Hermanowski T., Jakubczyk M., Golicki D., Macioch T., abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 329; Health State Utilities Estimated in Polish Cardiac Patients, Poster Presentation, Zawodnik Sz., Golicki D., Hermanowski T., abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 361; 4. Cost of Pompe Disease in Poland in 2008 and 2009, Baran A., Czech M., Hermanowski T., abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 464; 5. Pharmacy Network Development During Economic Transition in Poland, Tuszyńska M., Hermanowski T., Feliksiak H., abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 427; 6. Indirect Costs of Pregnancy, Parturition and Puerperium in Poland, Szkołut S., Jakubczyk M., Hermanowski T., abstract in Value in Health, ISPOR

7 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 379; 7. Indirect Costs of Obesity in Poland, Warowny M., Macioch T., Hermanowski T., abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 464; 8. The Impact of Employees Work Absenteeism Due to Care for a Sick Person on Productivity in Poland, Poster Presentation, Wrona W., Hermanowski T., Jakubczyk M., Czech M., abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 379; 9. A Comparison of Hta Recommendations for Cancer Treatment Technologies Published by Agency for Health Technology Assessment (Antapol) and National Institute for Health and Clinical Excellence (Nice), Kiljan A., Kolasa K., Hermanowski T., abstract in Value in Health, ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010, p. 280; 10. Paweł Kawalec, Marcin Czech - Cost of Diabetes Mellitus Type 1 and 2 Studies in Countries of Central and Eastern Europe - a Systematic Review of the Literature. Abstract in Value in Health ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010; 11. Johan Erpur Adalsteinsson, Marcin Czech, Iwona Skrzekowska- Baran - Health Technology Assessment of Diabetes Compounds: the Polish Perspective.Abstract in Value in Health ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010; 12. Maciej Niewada, Witold Wrona, Agata Schubert, Iwona Skrzekowska- Baran, Marcin Czech - Long-Term Cost-Effectiveness of Liraglutide vs. Sulphonylurea in Poland.Abstract in Value in Health ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010; 13. Anna Ivanova, Guenka Petrova, Witold Wrona, Vassil Valov, Marcin Czech - Economic Evaluation of Liraglutide vs. Rosiglitazone or Exenatide for Type 2 Diabetes Mellitus in Bulgaria. Abstract in Value in Health ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010 ; 14. Dorin Ionescu, Maciej Niewada, Marcin Czech - Liraglutide in the Treatment of Type 2 Diabetes Mellitus Economic Evaluation in Romanian Setting Abstract in Value in Health ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010; 15. Tomas Dolezal, Maciej Niewada, Karel Rychna, Marcin Czech - Long- Term Cost-Effectiveness of Liraglutide vs. Rosiglitazone in the Czech Republic; 16. Anna Ilavská, V Uličiansky, Witold Wrona, Jozef Lacka, Marcin Czech - Cost-Effectiveness of Liraglutide in People with Type 2 Diabetes in the Slovak Republic. Abstract in Value in Health ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010; 17. Witold Wrona, Tomasz Hermanowski, Michał Jakubczyk, Marcin Czech - The Impact of Employees Work Absenteeism Due to Care for a Sick Person on Productivity in Poland. Abstract in Value in Health ISPOR 13th Annual European Congress, Vol. 13, No 7, November 2010.

8 ISPOR POLAND Chapter Polish Society of Pharmacoeconomics set up in 2010 five sections: 1. Epidemiology and costs of diseases 2. Health Technology Assessment 3. Health-related quality of life 4. Pharmacoeconomic analysis methodologies 5. Therapeutic programs and Pharmaceutical Care Other Date Month or TBD Upcoming Activities for ISPOR Poland Chapter 2011 Activities December, Organisation of The 9 th Scientific Conference of the Polish Society of 2011 Pharmacoeconomics May 2011 November 2011 Active participation in 16 th International Meeting in Baltimore Active participation in ISPOR 14th Annual European Congress in Madrid Cooperation with ISPOR, particularly developing close contacts with Central and Eastern Europe Chapters,

INVITATION. Health status assessment for health economic evaluations: opportunities and challenges in Central and Eastern European countries

INVITATION. Health status assessment for health economic evaluations: opportunities and challenges in Central and Eastern European countries Corvinus Health Policy and Health Economics Conference Series 2018/7 Department of Health Economics, Corvinus University of Budapest in cooperation with: Health Economics Study Circle, Corvinus University